<DOC>
	<DOCNO>NCT00139243</DOCNO>
	<brief_summary>The purpose study determine safety maximum tolerate dose combination taxotere , cisplatin , 5-fluorouracil leucovorin . We also preliminarily ass whether combination effective treat squamous cell carcinoma head neck .</brief_summary>
	<brief_title>Study Taxotere , Cisplatin , 5-Fluorouracil , Leucovorin Squamous Cell Carcinoma Head Neck</brief_title>
	<detailed_description>- Patients premedicated home dexamethasone leucovorin . - On first day treatment , patient receive taxotere intravenously one hour . Approximately one hour taxotere complete , patient receive 4 hour infusion cisplatin begin four day continuous infusion 5-fluorouracil leucovorin . The infusion 5-fluorouracil leucovorin complete home use infusion pump . This process repeat every 21-35 day ( 1 cycle ) depend upon quickly patient recovers chemotherapy . - During cycle blood test perform weekly . During first cycle physical exam perform weekly halfway subsequent cycle immediately prior start subsequent cycle . - At end cycle impact chemotherapy assess . If 2 cycle cancer respond treatment end . If significant reduction size tumor observe , third final cycle do . - After last cycle chemotherapy do , radiation therapy perform twice daily 6-7 week .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologic documentation squamous cell carcinoma head neck Patients previously untreated stage III IV squamous cell carcinoma . Patients locally recurrent disease surgery . Life expectancy longer 3 month . Kidney function : 1.5 24 hour creatinine clearance &gt; 30ml/min Liver function : SGOT &lt; 1.5 X upper normal limit alkaline phosphatase &lt; 2.5 X upper normal limit . WBC great equal 4,000/mm Platelet count great equal 100,000/mm Hemoglobin great equal 10gm/dl Patients childbearing age must use effective method contraception . Patients treat previous chemotherapy radiotherapy head neck cancer . Patients concurrent malignancy site except limited basal cell carcinoma , squamous carcinoma skin carcinoma situ cervix . Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>squamous cell carcinoma</keyword>
	<keyword>Taxotere</keyword>
	<keyword>carcinoma head/neck</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>5-Fluorouracil</keyword>
	<keyword>Leucovorin</keyword>
</DOC>